Allergan PLC (AGN)

NYSE

Currency in USD

Disclaimer

193.02

0.00(0.00%)

Closed08/05

Fair Value

Day's Range

191.64

193.38

52 wk Range

0.00

193.38

AGN Income Statement

Featured here, the Income Statement (earnings report) for Allergan PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2010

31/12

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

Total Revenues

12,688.1

14,570.6

15,940.7

15,787.4

16,088.9

Total Revenues Growth

+171.32%

+14.84%

+9.4%

-0.96%

+1.91%

Cost Of Revenues

1,469.2

1,804.7

2,145.4

2,266

2,434.5

Gross Profit

11,218.9

12,765.9

13,795.3

13,521.4

13,654.4

Gross Profit Growth

+203.79%

+13.79%

+8.06%

-1.99%

+0.98%

Gross Profit Margin %

88.42%

87.61%

86.54%

85.65%

84.87%

Other Operating Expenses, Total

11,184.2

13,131.1

13,730

13,136.3

12,232.9

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+156.96%	+17.41%	+4.56%	-4.32%	-6.88%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,067.2	2,568.5	1,990.6	2,253.4	1,791.8
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3,673.3	4,092.2	4,542.3	4,330.6	4,584.5
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

34.7

-365.2

65.3

385.1

1,421.5

Operating Income Growth

+105.26%

-1,152.45%

+117.88%

+489.74%

+269.12%

EBIT Margin %

0.27%

-2.51%

0.41%

2.44%

8.84%

Net Interest Expenses

-1,182.7

-1,157.5

-942.7

-866

-706.2

Net Interest Expenses Growth

-192.97%

+2.13%

+18.56%

+8.14%

+18.45%

Interest Expense, Total

-1,193.3

-1,295.6

-1,095.6

-911.2

-783

Interest And Investment Income

10.6

138.1

152.9

45.2

76.8

Other Non Operating Expenses, Total

5.4

-7.5

-8.9

-15.1

8

EBT, Excl. Unusual Items

-1,142.6

-1,530.2

-886.3

-496

723.3

Gain (Loss) On Sale Of Assets

-15.5

-5

-51.7

-843.6

-126.2

Other Unusual Items, Total

-869.1

-797

-5,460.8

-2,570.6

-1,971.6

EBT, Incl. Unusual Items

-4,547.5

-2,832

-10,386.4

-6,856.9

-5,118.7

EBT, Incl. Unusual Items Growth

-51.67%

+37.72%

-266.75%

+33.98%

+25.35%

EBT, Incl. Unusual Items Margin

-35.84%

-19.44%

-65.16%

-43.43%

-31.82%

Income Tax Expense

-1,605.9

-1,897

-6,670.4

-1,770.7

146.4

Net Income to Company

3,919.4

14,979.5

-4,118.9

-5,086.2

-5,265.1

Minority Interest

-4.2

-6.1

-6.6

-10.2

-5.9

Net Income

3,915.2

14,973.4

-4,125.5

-5,096.4

-5,271

Net Income Growth

+340.12%

+282.44%

-127.55%

-23.53%

-3.43%

Net Income Margin %

30.86%

102.76%

-25.88%

-32.28%

-32.76%

Preferred Dividend and Other Adjustments

232

278.4

278.4

46.4

-

Net Income to Common Excl. Extra Items

-3,177.8

-1,219.5

-4,001

-5,142.8

-5,271

Basic EPS - Continuing Operations

-8.64

-3.17

-11.99

-15.26

-16.02

Basic EPS - Continuing Operations Growth

+23.6%

+63.33%

-278.31%

-27.32%

-4.99%

Diluted EPS - Continuing Operations

-8.64

-3.17

-11.99

-15.26

-16.02

Diluted EPS - Continuing Operations Growth

+23.61%

+63.31%

-278.23%

-27.28%

-4.99%

Basic Weighted Average Shares Outstanding

367.8

384.9

333.8

337

329

Diluted Weighted Average Shares Outstanding

367.8

384.9

333.8

337

329

Dividend Per Share

-

-

2.8

2.88

2.96

Dividend Per Share Growth

-

-

-

+2.86%

+2.78%

EBITDA

5,603

6,258.9

7,433.9

7,133.7

7,482.6

EBITDA Growth

+316.86%

+11.71%

+18.77%

-4.04%

+4.89%

EBITDA Margin %

44.16%

42.96%

46.63%

45.19%

46.51%

EBIT

34.7

-365.2

65.3

385.1

1,421.5

* In Millions of USD (except for per share items)